Patterson-UTI Energy Inc (NASDAQ: PTEN): To Buy Or Not To Buy, That Is The Question

Patterson-UTI Energy Inc (PTEN) concluded trading on Wednesday at a closing price of $8.56, with 9.44 million shares of worth about $80.8 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.90% during that period and on April 03, 2025 the price saw a gain of about 2.15%. Currently the company’s common shares owned by public are about 387.34M shares, out of which, 348.17M shares are available for trading.

Stock saw a price change of -0.12% in past 5 days and over the past one month there was a price change of 13.98%. Year-to-date (YTD), PTEN shares are showing a performance of 3.63% which decreased to -27.15% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.03 but also hit the highest price of $12.65 during that period. The average intraday trading volume for Patterson-UTI Energy Inc shares is 10.52 million. The stock is currently trading 6.04% above its 20-day simple moving average (SMA20), while that difference is up 3.35% for SMA50 and it goes to -0.72% lower than SMA200.

Patterson-UTI Energy Inc (NASDAQ: PTEN) currently have 387.34M outstanding shares and institutions hold larger chunk of about 98.04% of that.

The stock has a current market capitalization of $3.31B and its 3Y-monthly beta is at 1.29. It has posted earnings per share of -$2.48 in the same period. It has Quick Ratio of 1.34 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PTEN, volatility over the week remained 4.02% while standing at 4.37% over the month.

Stock’s fiscal year EPS is expected to rise by 58.59% while it is estimated to increase by 613.96% in next year.

Coverage by Goldman stated Patterson-UTI Energy Inc (PTEN) stock as a Buy in their note to investors on December 13, 2024, suggesting a price target of $10 for the stock. On January 16, 2024, The Benchmark Company Downgrade their recommendations, while on December 19, 2023, Goldman Initiated their ratings for the stock with a price target of $12. Stock get an Equal-weight rating from Morgan Stanley on October 17, 2023.

Most Popular

Related Posts